Viewing Study NCT01275066


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-01-02 @ 9:17 AM
Study NCT ID: NCT01275066
Status: COMPLETED
Last Update Posted: 2014-07-07
First Post: 2011-01-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
Sponsor: BioMarin Pharmaceutical
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: MOR-004
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators